Alpha-9 Oncology Inc
Alpha-9 Oncology Inc is a clinical-stage company focused on developing radiopharmaceuticals to enhance cancer treatment. The company is advancing a distinctive pipeline of targeted therapies through clinical studies aimed at addressing tumors with high unmet patient needs. Alpha-9 is also investing in discovery capabilities and expanding its manufacturing and isotope supply partnerships to support its growing portfolio.
Leadership & Board
- Current Number of Employees
- 47
- Current LinkedIn Followers
- 13,010
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $175M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $175M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Employee Trend
Alpha-9 Oncology Inc had 47 employees as of October 12, 2026. The number of employees increased by 3 (6.82%) week-over-week.
Social Trend
Alpha-9 Oncology Inc had 13,010 followers as of October 12, 2026. The number of followers increased by 39 (0.30%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series C | $175.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| General Catalyst | Series C |
| Samsara BioCapital | Series C |
| RA Capital Management | Series C |
| Janus Henderson Investors | Series C |
| Lightspeed Venture Partners | Series C |
| Ascenta Capital | Series C |
| a16z Bio + Health | Series C |
| Delos Capital | Series C |
Similar Companies
A snapshot of private companies similar to Alpha-9 Oncology Inc, helping you discover and navigate related company profiles.
Related News and Analysis
